tiprankstipranks
Cara Therapeutics (DE:69C)
BERLIN:69C

Cara Therapeutics (69C) Ownership - Who Owns Cara Therapeutics?

1 Followers

Cara Therapeutics (69C) Ownership Overview

0.00%0.00%3.18%96.82%
3.18% Other Institutional Investors
96.82% Public Companies and
Individual Investors
The ownership structure of Cara Therapeutics (DE:69C) stock is a mix of institutional, retail and individual investors. Approximately 3.18% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 96.82% is owned by Public Companies and Individual Investors.
The ownership structure of Cara Therapeutics (DE:69C) stock is a mix of institutional, retail and individual investors. Approximately 3.18% of the company’s stock is owned by Institutional Investors, 0.00% is owned by Insiders and 96.82% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Currently, No Data Available
Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$12697
Dec 31, 2023Sold$1156294

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
314,988Insider209,782
28,000Insider18,648
109,712Insider73,068
1,314,338Insider875,349
2,000Insider1,332
991,405Insider660,276
47,838Insider31,860
57,438Insider38,254
167,247Insider111,387
1,677,924Institution1,196,360

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
106,260Institution75,763
62,475Institution44,545
2,880Institution2,053
22,680Institution16,171
2,699Institution1,924
28,050Institution20,000
11,140Institution7,943
41,705Institution29,736
157,143Institution112,043
233,703Institution166,630

Top ETF Holders

Currently, No Data Available
Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Cara Therapeutics (DE:69C)?
According to the latest TipRanks data, approximately 3.18% of the company's stock is held by institutional investors, 0.00% is held by insiders, and 96.82% is held by retail investors.
    What percentage of Cara Therapeutics (DE:69C) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 3.18% of Cara Therapeutics (DE:69C) stock is held by institutional investors.
      What percentage of Cara Therapeutics (DE:69C) stock is held by retail investors?
      According to the latest TipRanks data, approximately 96.82% of Cara Therapeutics (DE:69C) stock is held by retail investors.
        Who owns the most shares of Cara Therapeutics (DE:69C)?
        Michael E. Lewis owns the most shares of Cara Therapeutics (DE:69C).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis